Interferon beta in multiple sclerosis: how much BENEFIT?
Pittock
Sean J
SJ
Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55901, USA. Pittock.Sean@mayo.edu
D002986:Clinical Trials as Topic; D003657:Decision Making; D004185:Disability Evaluation; D004334:Drug Administration Schedule; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016899:Interferon-beta / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy*; D012720:Severity of Illness Index; D013997:Time Factors
D007155:Immunologic Factors; D016899:Interferon-beta